The Weight-Loss Pill Has Arrived: What Orforglipron (Foundayo) Means for Ireland
Orforglipron (Foundayo) is the first GLP-1 weight-loss pill โ no needle, approved in the US in 2026. What the ATTAIN-1 clinical trial shows, how the tablet compares to Ozempic and Wegovy, and when the weight-loss pill will reach Ireland. A pharmacist’s guide from Laois Pharmacy.
